The Effect of Su-Jok Application and Progressive Muscle Relaxation Exercises in Coping With Premenstrual Syndrome

NCT ID: NCT06296043

Last Updated: 2024-06-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

135 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-04-10

Study Completion Date

2024-08-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to determine the effect of su-jok application and progressive muscle relaxation exercise in coping with premenstrual syndrome.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Various medications can be used to relieve PMS symptoms, but there is no treatment to completely eliminate it. For this reason, women may seek traditional and alternative practices to reduce PMS complaints. Alternative methods such as herbal treatment, aromatherapy, acupuncture, nutrition regulation and stress control can be used to relieve PMS symptoms. It has been stated that applying mind-body based therapies to relieve PMS symptoms is safe and cost-effective. Such interventions include progressive muscle relaxation exercise (PCGE), paced breathing, clinical hypnosis, yoga, mindfulness, reflexology, and cognitive behavioral therapies. Su-Jok application, which is an alternative method, can also be used to relieve PMS symptoms. In Su-Jok therapy, the practitioner stimulates points on the hands and feet to activate auto-regulatory mechanisms and bring the body to a healthy state. Due to the negative effects of PMS on daily life, knowing the frequency of occurrence and risk factors is expected to contribute and guide individuals in coping with PMS. While PMS threatens the health of the individual in particular, it generally brings socio-economic burdens to the individual, family and society.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Premenstrual Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Three groups with su-jok group, progressive muscle relaxation exercise group and control group
Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

SINGLE

Participants
Double (Participant, Outcomes Assessor) Since the application will be performed by the researcher, participant will be blinded in this study. The statistician will be blinded in the evaluation of the data.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Progressive Muscle Relaxation Exercise Group

Application will be made on the day PMS symptoms begin and throughout the menstrual cycle.

Group Type EXPERIMENTAL

Progressive Muscle Relaxation Exercise Group

Intervention Type PROCEDURE

Exercise Group

Su-Jok Group

Application will be made on the day PMS symptoms begin and throughout the menstrual cycle.

Group Type EXPERIMENTAL

Su-Jok Intervention

Intervention Type PROCEDURE

Hand massage with seeds

Control Group

No application will be made to this group by the researcher.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Progressive Muscle Relaxation Exercise Group

Exercise Group

Intervention Type PROCEDURE

Su-Jok Intervention

Hand massage with seeds

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Getting over 104 points from the PMS scale,
* Having regular menstruation,
* Not having any chronic disease,
* Not using any method to cope with PMS.

Exclusion Criteria

* Having irregular menstruation,
* Having musculoskeletal system and respiratory diseases,
* Having a diagnosed psychiatric disease,
* Having a disease that may cause premenstrual symptoms and receiving medical treatment (thyroid diseases, heart failure, neurological disorders)
Minimum Eligible Age

18 Years

Maximum Eligible Age

30 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Saglik Bilimleri Universitesi

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Filiz Ünal Toprak, PhD

Role: PRINCIPAL_INVESTIGATOR

Saglik Bilimleri Universitesi

Sevil Albayrak, PhD

Role: PRINCIPAL_INVESTIGATOR

Kıbrıs İlim Üniversitesi

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Sağlık Bilimleri Üniversitesi

Ankara, , Turkey (Türkiye)

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Filiz Ünal Toprak, PhD

Role: CONTACT

05077732090

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Filiz Ünal Toprak, PhD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SBU-FUT-01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.